Johansson L, Akerlund A, Holmberg K, Melen I, Bende M. Prevalence of nasal polyps in adults: the Skovde population-based study. Ann Otol Rhinol Laryngol. 2003;112(7):625–9.

Article  PubMed  Google Scholar 

Campion NJ, Kohler R, Ristl R, Villazala-Merino S, Eckl-Dorna J, Niederberger-Leppin V. Prevalence and symptom burden of nasal polyps in a large Austrian population. J Allergy Clin Immunol Pract. 2021;9(11):4117-4129 e2.

Article  CAS  PubMed  Google Scholar 

Bhattacharyya N, Villeneuve S, Joish VN, Amand C, Mannent L, Amin N, et al. Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps. Laryngoscope. 2019;129(9):1969–75.

Article  PubMed  PubMed Central  Google Scholar 

Bachert C, Bhattacharyya N, Desrosiers M, Khan AH. Burden of disease in chronic rhinosinusitis with nasal polyps. J Asthma Allergy. 2021;14:127–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu DT, Bartosik TJ, Campion NJ, Bayer K, Tu A, Victoria S, et al. Chronic rhinosinusitis symptoms differentially impact the likelihood of major depressive disorders. Laryngoscope Investig Otolaryngol. 2022;7(1):29–35.

Article  PubMed  PubMed Central  Google Scholar 

Jankowski R, Bouchoua F, Coffinet L, Vignaud JM. Clinical factors influencing the eosinophil infiltration of nasal polyps. Rhinology. 2002;40(4):173–8.

CAS  PubMed  Google Scholar 

Bachert C, Zhang N, Holtappels G, De Lobel L, van Cauwenberge P, Liu S, et al. Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol. 2010;126(5):962–8.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Gevaert E, Lou H, Wang X, Zhang L, Bachert C, et al. Chronic rhinosinusitis in Asia. J Allergy Clin Immunol. 2017;140(5):1230–9.

Article  PubMed  Google Scholar 

Alobid I, Bernal-Sprekelsen M, Mullol J. Chronic rhinosinusitis and nasal polyps: the role of generic and specific questionnaires on assessing its impact on patient’s quality of life. Allergy. 2008;63(10):1267–79.

Article  CAS  PubMed  Google Scholar 

Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl S29):1–464.

PubMed  Google Scholar 

Bachert C, Zinreich SJ, Hellings PW, Mullol J, Hamilos DL, Gevaert P, et al. Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP. Rhinology. 2020;58(1):10–7.

PubMed  Google Scholar 

Hopkins C, Wagenmann M, Bachert C, Desrosiers M, Han JK, Hellings PW, et al. Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2021;11(7):1087–101.

Article  PubMed  PubMed Central  Google Scholar 

Gevaert P, Omachi TA, Corren J, Mullol J, Han J, Lee SE, et al. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol. 2020;146(3):595–605.

Article  CAS  PubMed  Google Scholar 

Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394(10209):1638–50.

Article  CAS  PubMed  Google Scholar 

Bachert C, Han JK, Wagenmann M, Hosemann W, Lee SE, Backer V, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol. 2021;147(1):29–36.

Article  CAS  PubMed  Google Scholar 

European Medicines Agency, Section on Therapeutic Indications of Dupilumab https://www.ema.europa.eu/en/medicines/human/EPAR/dupixent#:~:text=those%20given%20placebo.,Chronic%20rhinosinusitis%20with%20nasal%20polyposis,patients%27%20perception%20of%20nasal%20congestion. Accessed 19 Apr 2023.

Oleszkiewicz A, Schriever VA, Croy I, Hahner A, Hummel T. Updated Sniffin’ Sticks normative data based on an extended sample of 9139 subjects. Eur Arch Otorhinolaryngol. 2019;276(3):719–28.

Article  CAS  PubMed  Google Scholar 

Riedl D, Dejaco D, Steinbichler TB, Innerhofer V, Gottfried T, Bektic-Tadic L, et al. Assessment of health-related quality-of-life in patients with chronic rhinosinusitis—validation of the German Sino-Nasal Outcome Test-22 (German-SNOT-22). J Psychosom Res. 2021;140:110316.

Article  CAS  PubMed  Google Scholar 

Koller M. robustlmm: an R package for robust estimation of linear mixed-effects models. J Stat Softw. 2016;75(6):1–24.

Article  Google Scholar 

Feng AL, Wesely NC, Hoehle LP, Phillips KM, Yamasaki A, Campbell AP, et al. A validated model for the 22-item Sino-Nasal Outcome Test subdomain structure in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017;7(12):1140–8.

Article  PubMed  Google Scholar 

De Corso E, Settimi S, Montuori C, Corbo M, Passali GC, Porru DP, et al. Effectiveness of dupilumab in the treatment of patients with severe uncontrolled CRSwNP: a “real-life” observational study in the first year of treatment. J Clin Med. 2022;11(10):2684.

Article  PubMed  PubMed Central  Google Scholar 

Scangas GA, Wu AW, Ting JY, Metson R, Walgama E, Shrime MG, et al. Cost utility analysis of dupilumab versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps. Laryngoscope. 2020;131:E26–33.

PubMed  Google Scholar 

Loftus CA, Soler ZM, Koochakzadeh S, Desiato VM, Yoo F, Nguyen SA, et al. Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta-analysis of risk factors. Int Forum Allergy Rhinol. 2020;10(2):199–207.

Article  PubMed  Google Scholar 

Calus L, Van Bruaene N, Bosteels C, Dejonckheere S, Van Zele T, Holtappels G, et al. Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis. Clin Transl Allergy. 2019;9:30.

Article  PubMed  PubMed Central  Google Scholar 

DeConde AS, Mace JC, Levy JM, Rudmik L, Alt JA, Smith TL. Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2017;127(3):550–5.

Article  PubMed  Google Scholar 

Seys SF, De Bont S, Fokkens WJ, Bachert C, Alobid I, Bernal-Sprekelsen M, et al. Real-life assessment of chronic rhinosinusitis patients using mobile technology: the mySinusitisCoach project by EUFOREA. Allergy. 2020;75(11):2867–78.

Article  PubMed  Google Scholar 

Besser G, Liu DT, Renner B, Hummel T, Mueller CA. Olfactory implant: demand for a future treatment option in patients with olfactory dysfunction. Laryngoscope. 2019;129(2):312–6.

Article  PubMed  Google Scholar 

Ge W, Wang D, Chuang CC, Li Y, Rout R, Siddiqui S, et al. Real-world cost of nasal polyps surgery and risk of major complications in the United States: a descriptive retrospective database analysis. Clinicoecon Outcomes Res. 2022;14:691–7.

Article  PubMed  PubMed Central  Google Scholar 

Wang X, Zhang N, Bo M, Holtappels G, Zheng M, Lou H, et al. Diversity of T(H) cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol. 2016;138(5):1344–53.

Article  CAS  PubMed  Google Scholar 

Orlandi RR, Kingdom TT, Smith TL, Bleier B, DeConde A, Luong AU, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11(3):213–739.

Article  PubMed  Google Scholar 

Parasher AK, Gliksman M, Segarra D, Lin T, Rudmik L, Quast T. Economic evaluation of dupilumab versus endoscopic sinus surgery for the treatment of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2022;12(6):813–20.

Article  PubMed  Google Scholar 

Meier EC, Schmid-Grendelmeier P, Steiner UC, Soyka MB. Real-life experience of monoclonal antibody treatments in chronic rhinosinusitis with nasal polyposis. Int Arch Allergy Immunol. 2021;182(8):736–43.

Article  CAS  PubMed  Google Scholar 

Nettis E, Brussino L, Patella V, Bonzano L, Detoraki A, Di Leo E, et al. Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life. Clin Mol Allergy. 2022;20(1):6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mullol J, Bachert C, Amin N, Desrosiers M, Hellings PW, Han JK, et al. Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2022;10(4):1086-1095 e5.

Article  CAS  PubMed  Google Scholar 

Agache I, Song Y, Alonso-Coello P, Vogel Y, Rocha C, Sola I, et al. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines. Allergy. 2021;76(8):2337–53.

Article  CAS  PubMed  Google Scholar 

Canonica GW, Bourdin A, Peters AT, Desrosiers M, Bachert C, Weidinger S, et al. Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases. J Allergy Clin Immunol Pract. 2022;10(6):1515–26.

Article  CAS  PubMed  Google Scholar 

Lee SE, Hopkins C, Mullol J, Msihid J, Guillemin I, Amin N, et al. Dupilumab improves health related quality of life: results from the phase 3 SINUS studies. Allergy. 2022;77:2211–21.

Article  CAS  PubMed